- Home
- ICAD vs CLNN Comparison
ICAD vs CLNN Comparison
Compare ICAD & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- CLNN
- Stock Information
- Founded
- ICAD 1984
- CLNN 2012
- Country
- ICAD United States
- CLNN United States
- Employees
- ICAD N/A
- CLNN N/A
- Industry
- ICAD Medical/Dental Instruments
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- CLNN Health Care
- Exchange
- ICAD Nasdaq
- CLNN Nasdaq
- Market Cap
- ICAD 40.8M
- CLNN 43.0M
- IPO Year
- ICAD 1986
- CLNN N/A
- Fundamental
- Price
- ICAD $1.64
- CLNN $4.53
- Analyst Decision
- ICAD
- CLNN Strong Buy
- Analyst Count
- ICAD 0
- CLNN 4
- Target Price
- ICAD N/A
- CLNN $59.25
- AVG Volume (30 Days)
- ICAD 257.0K
- CLNN 54.9K
- Earning Date
- ICAD 11-13-2024
- CLNN 11-13-2024
- Dividend Yield
- ICAD N/A
- CLNN N/A
- EPS Growth
- ICAD N/A
- CLNN N/A
- EPS
- ICAD N/A
- CLNN N/A
- Revenue
- ICAD $18,940,000.00
- CLNN $421,000.00
- Revenue This Year
- ICAD $13.15
- CLNN N/A
- Revenue Next Year
- ICAD $24.28
- CLNN $1,058.37
- P/E Ratio
- ICAD N/A
- CLNN N/A
- Revenue Growth
- ICAD 10.03
- CLNN N/A
- 52 Week Low
- ICAD $1.18
- CLNN $3.82
- 52 Week High
- ICAD $2.65
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- ICAD 42.66
- CLNN 34.27
- Support Level
- ICAD $1.72
- CLNN $5.00
- Resistance Level
- ICAD $2.05
- CLNN $6.04
- Average True Range (ATR)
- ICAD 0.15
- CLNN 0.52
- MACD
- ICAD -0.02
- CLNN -0.17
- Stochastic Oscillator
- ICAD 0.00
- CLNN 8.80
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).